Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

NCT00000940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ritonavir
DRUG: Abacavir sulfate
DRUG: Amprenavir
DRUG: Lamivudine
DRUG: Stavudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)